MRC1 and neoplasm: The identification of MMR as a marker for M2-like TAMs, residing in hypoxic tumor areas (10, 25), enables the visualization of these pro-tumoral macrophages for diagnostic purposes using anti-MMR Nanobodies in vivo (38, 39) and could potentially be coupled to toxic moieties for selective depletion of M2-like TAMs (40).